Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Jones

Showing results (341-350 of 414) with videos related to

Pageof 42
Sort By:
Human Molecular Genetics|August 11, 1999
Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtinJ M Boutell, P Thomas, J W Neal, et al.
Human & Experimental Toxicology|January 11, 2007
Should all patients with unexplained anaemia be screened for chronic lead poisoning?I B Gawarammana, P I Dargan, S Woodcock, et al.
Nucleic Acids Research|April 11, 1995
Discordant expression and variable numbers of neighboring GGA- and GAA-rich triplet repeats in the 3' untranslated regions of two groups of messenger RNAs encoded by the rat polymeric immunoglobulin receptor geneK S Koch, A S Gleiberman, T Aoki, et al.
Biochemical Society Transactions|October 10, 1998
Full length huntingtin is not detected in intranuclear inclusions in Huntington's disease brainP Thomas, F Wilkinson, T M Nguyen, et al.
The European Physical Journal. E, Soft Matter|March 11, 2004
The timescale of spinodal dewetting at a polymer/polymer interfaceA M Higgins, M Sferrazza, R A L Jones, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2011
UK guidance document: treatment of metastatic breast cancerR E Coleman, G Bertelli, T Beaumont, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
SAC3 may link nuclear protein export to cell cycle progressionA L Jones, B B Quimby, J K Hood, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanomaA L Jones, M E O'Brien, A Lorentzos, et al.
Emergency Medicine Journal : EMJ|November 27, 2008
Doctors' knowledge of the appropriate use and route of administration of antidotes in the management of recreational drug toxicityS Lidder, H Ovaska, J R H Archer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Pageof 42

Showing results (341-350 of 414) with videos related to

Sort By:
Pageof 42
Human Molecular Genetics|August 11, 1999
Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtinJ M Boutell, P Thomas, J W Neal, et al.
Human & Experimental Toxicology|January 11, 2007
Should all patients with unexplained anaemia be screened for chronic lead poisoning?I B Gawarammana, P I Dargan, S Woodcock, et al.
Nucleic Acids Research|April 11, 1995
Discordant expression and variable numbers of neighboring GGA- and GAA-rich triplet repeats in the 3' untranslated regions of two groups of messenger RNAs encoded by the rat polymeric immunoglobulin receptor geneK S Koch, A S Gleiberman, T Aoki, et al.
Biochemical Society Transactions|October 10, 1998
Full length huntingtin is not detected in intranuclear inclusions in Huntington's disease brainP Thomas, F Wilkinson, T M Nguyen, et al.
The European Physical Journal. E, Soft Matter|March 11, 2004
The timescale of spinodal dewetting at a polymer/polymer interfaceA M Higgins, M Sferrazza, R A L Jones, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2011
UK guidance document: treatment of metastatic breast cancerR E Coleman, G Bertelli, T Beaumont, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
SAC3 may link nuclear protein export to cell cycle progressionA L Jones, B B Quimby, J K Hood, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanomaA L Jones, M E O'Brien, A Lorentzos, et al.
Emergency Medicine Journal : EMJ|November 27, 2008
Doctors' knowledge of the appropriate use and route of administration of antidotes in the management of recreational drug toxicityS Lidder, H Ovaska, J R H Archer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Pageof 42